SICUR 2026 Brokerage Event - Cluster 3

24–26 Feb 2026 | Madrid, Spain

Project cooperationUpdated on 19 January 2026

Horizon Europe Cluster 3 Cooperation on Rapid Hemostasis Solutions

CEO at Genexica Biotech

Menidi Aetolias-Akarnanias, Greece

About

We are seeking project cooperation partners within Horizon Europe Cluster 3 - Civil Security for Society to jointly develop, validate and demonstrate an innovative rapid hemostasis gel barrier for emergency and disaster response.

The technology aims to address unmet needs in civil protection, first responder operations and disaster-resilient healthcare, where rapid bleeding control is critical and conventional solutions are insufficient.

We are interested in collaborating with research organisations, civil protection authorities, emergency services, SMEs and system integrators for activities including laboratory validation, field testing, user-driven requirements, regulatory pathways and integration into emergency response systems.

Our goal is to contribute a strong biotechnology and applied R&D component to a multidisciplinary consortium targeting real-world deployment and societal impact.

Stage

  • Execution - Development stage (preparation)

Call

  • Fighting Crime and Terrorism
  • Disaster-resilient society

Type

  • Research and Innovation Action
  • Innovation Action
  • Coordination and Support Action

Organisation

Genexica Biotech

Company

Menidi Aetolias-Akarnanias, Greece

Similar opportunities